Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Investor Road Show_June 18 and 19, 2024
June 14, 2024
Investor Road Show_June 05 and 06, 2024
June 6, 2024
Press release- Orchid receives DCGI approval for Cefepime and Enmetazobactam
June 6, 2024
Newspaper Publication of Audited Financial Results_March 31, 2024
May 25, 2024
Report on Related Party Transaction_March 31, 2024
May 24, 2024
Outcome of Board Meeting_May, 2024
May 23, 2024
Statement of Deviation/ Variation_Q4-2023-24
May 23, 2024
Press Release- Orchid Pharma announces Q4 results with 71.60% growth in annual PAT
May 23, 2024
Appointment of Independent Director_Shubha Singh
May 23, 2024
Prior intimation of Board Meeting_May, 2024
May 17, 2024
Monitoring Agency Report_March 31, 2024
May 15, 2024
GST Order Disclosure_May 2024
May 2, 2024
Certificate under Reg 7(3) of SEBI (LODR) Reg, 2015_March 31, 2024
April 20, 2024
Corporate Governance Report_March 31, 2024
April 20, 2024
Reconciliation of Share Capital Audit Report_March 31, 2024
April 19, 2024
Certificate under Regulation 40(9) of SEBI (LODR) Reg, 2015_March 31, 2024
April 19, 2024
Previous
1
...
Next
8 / 36